Clinical Pharmacology and Drug Toxicity — MCQs

A 29-year-old medical student developed a positive PPD test and was started on isoniazid (INH) and rifampin prophylaxis. Three months into her therapy, she began to experience muscle fasciculations and convulsions. Administration of which of the following vitamins might have prevented these symptoms?

Q339Easy

All of the following drugs are nephrotoxic, EXCEPT:

Q340Easy

Which of the following is not an ototoxic drug?

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 331: In methyl alcohol poisoning, CNS depression, cardiac depression, and optic nerve atrophy occur. What are these effects due to?

A. Formaldehyde and formic acid (Correct Answer)
B. Acetaldehyde
C. Pyridine
D. Acetic acid

Explanation: ### Explanation **Mechanism of Toxicity** Methyl alcohol (Methanol) itself is relatively non-toxic, causing only mild CNS depression. The severe clinical manifestations occur due to its **metabolism** in the liver. Methanol is oxidized by the enzyme **Alcohol Dehydrogenase (ADH)** into **Formaldehyde**, which is then rapidly converted by **Aldehyde Dehydrogenase (ALDH)** into **Formic Acid**. * **Formaldehyde:** Highly reactive and primarily responsible for initial cellular damage. * **Formic Acid:** The main culprit for systemic toxicity. It inhibits mitochondrial cytochrome c oxidase, leading to cellular hypoxia and **metabolic acidosis** (High Anion Gap). It specifically targets the **optic nerve** (causing retinal edema and atrophy) and the **basal ganglia** (putaminal necrosis). **Analysis of Incorrect Options** * **B. Acetaldehyde:** This is the primary metabolite of **Ethyl alcohol** (Ethanol). Accumulation of acetaldehyde (e.g., in Disulfiram reaction) causes flushing, tachycardia, and nausea, but not optic atrophy. * **C. Pyridine:** A basic heterocyclic organic compound used as a solvent; it is not a metabolite of methanol. * **D. Acetic acid:** This is the end-product of ethanol metabolism (formed from acetaldehyde). It is non-toxic and enters the Kreb’s cycle. **High-Yield Clinical Pearls for NEET-PG** 1. **Clinical Triad:** CNS depression, severe metabolic acidosis, and visual disturbances ("snowstorm vision"). 2. **Antidote of Choice:** **Fomepizole** (inhibits Alcohol Dehydrogenase). 3. **Alternative Antidote:** **Ethanol** (has a higher affinity for ADH, preventing methanol breakdown). 4. **Adjuvant Therapy:** **Folate/Leucovorin** is administered to enhance the breakdown of formic acid into $CO_2$ and $H_2O$. 5. **Imaging:** MRI may show characteristic **bilateral putaminal necrosis**.

Question 332: Which of the following is NOT an immunosuppressant drug?

A. Cephalosporin (Correct Answer)
B. Cyclosporine
C. Azathioprine
D. Steroids

Explanation: ### Explanation The correct answer is **A. Cephalosporin**. **Why Cephalosporin is the correct answer:** Cephalosporins are a class of **beta-lactam antibiotics** used to treat bacterial infections. They work by inhibiting bacterial cell wall synthesis (binding to penicillin-binding proteins). They have no inherent immunosuppressive properties; rather, they are antimicrobial agents. **Analysis of Incorrect Options:** * **B. Cyclosporine:** This is a potent **calcineurin inhibitor**. It acts by inhibiting the transcription of Interleukin-2 (IL-2), which is essential for T-cell activation and proliferation. It is widely used in organ transplantation to prevent graft rejection. * **C. Azathioprine:** This is a **purine antimetabolite** (a prodrug of 6-mercaptopurine). It inhibits DNA synthesis, thereby suppressing the proliferation of rapidly dividing cells, particularly T and B lymphocytes. It is used in autoimmune conditions like SLE and Rheumatoid Arthritis. * **D. Steroids (Glucocorticoids):** These are the most commonly used immunosuppressants. They act via multiple mechanisms, including the inhibition of NF-κB, reduction of cytokine production (IL-1, IL-2, IL-6, TNF-α), and induction of T-cell apoptosis. **High-Yield Clinical Pearls for NEET-PG:** * **Cyclosporine Side Effects:** Remember the "5 H's"—**H**ypertension, **H**irsutism, **H**yperplasia (gingival), **H**yperlipidemia, and **H**epatotoxicity/Nephrotoxicity. * **Tacrolimus vs. Cyclosporine:** Tacrolimus is also a calcineurin inhibitor but is more potent and does *not* cause gingival hyperplasia or hirsutism (it may cause alopecia instead). * **Azathioprine Interaction:** Always check for **Allopurinol** use. Allopurinol inhibits xanthine oxidase, the enzyme that metabolizes 6-MP, leading to potentially fatal bone marrow toxicity.

Question 333: Therapeutic drug monitoring (TDM) is a process where plasma concentration of a drug is constantly monitored. What are the recommended therapeutic plasma concentration levels for Theophylline?

A. 10 - 20 mg/ml
B. 10 - 45 mg/ml
C. 4 - 12 mg/ml
D. 8 - 15 mg/ml (Correct Answer)

Explanation: Therapeutic Drug Monitoring (TDM) is essential for drugs with a **narrow therapeutic index**, where the difference between the effective dose and the toxic dose is minimal. [1] **Theophylline**, a methylxanthine used in bronchial asthma and COPD, is a classic example due to its wide inter-individual pharmacokinetic variation and potential for severe toxicity. [1] **1. Why Option D is Correct:** The traditionally cited therapeutic range for Theophylline was 10–20 µg/ml. However, modern clinical practice and updated pharmacological guidelines (reflected in recent NEET-PG patterns) recognize a safer, effective window of **8–15 µg/ml** (or 5–15 µg/ml). At levels above 20 µg/ml, the risk of toxicity increases significantly without a proportional increase in bronchodilation. **2. Analysis of Incorrect Options:** * **Option A (10–20 mg/ml):** While the numerical value is the "older" range, the **units are incorrect**. TDM for Theophylline is measured in **µg/ml** (micrograms), not mg/ml. 10 mg/ml would be a lethal concentration. * **Option B (10–45 mg/ml):** This range is far too high. Concentrations above 20–25 µg/ml are associated with severe toxicity, including cardiac arrhythmias and persistent seizures. [2] * **Option C (4–12 mg/ml):** This is the therapeutic range for **Carbamazepine**, another drug commonly requiring TDM. **3. High-Yield Clinical Pearls for NEET-PG:** * **Zero-Order Kinetics:** At high doses, Theophylline metabolism shifts from first-order to zero-order (saturation) kinetics, leading to a rapid, unpredictable rise in plasma levels. * **Toxicity Profile:** Characterized by GI upset, tachycardia, and the "Theophylline triad" of seizures, arrhythmias, and hypokalemia. [2] * **Drug Interactions:** Levels are **increased** by Enzyme Inhibitors (e.g., Ciprofloxacin, Erythromycin, Cimetidine) and **decreased** by Enzyme Inducers (e.g., Rifampicin, Phenytoin, Smoking). * **Other TDM Ranges to Remember:** Digoxin (0.5–2 ng/ml), Lithium (0.6–1.2 mEq/L), Phenytoin (10–20 µg/ml).

Question 334: Which of the following is NOT used for iron poisoning?

A. Penicillamine (Correct Answer)
B. Desferrioxamine
C. Gastric lavage
D. Magnesium hydroxide

Explanation: Explanation: The management of acute iron poisoning focuses on preventing further absorption and using specific chelation therapy [1]. Why Penicillamine is the correct answer: Penicillamine is a chelating agent primarily used for Copper toxicity (Wilson’s disease), Mercury, and Lead poisoning. It has no clinical role in the management of iron toxicity. In the context of NEET-PG, it is a common "distractor" in toxicology questions. Analysis of other options: * Desferrioxamine (B): This is the specific antidote (chelator) for iron poisoning. It binds ferric iron to form ferrioxamine, which is excreted in the urine (often turning urine a "vin-rose" color). * Gastric Lavage (C): This is indicated if the patient presents early (within 1 hour) after ingesting a significant amount of iron. However, it is often difficult because iron tablets are radiopaque and can form large, heavy masses (bezoars). * Magnesium Hydroxide (D): This can be used to precipitate iron in the stomach into insoluble forms, thereby reducing systemic absorption. High-Yield Clinical Pearls for NEET-PG: * Specific Antidote: Desferrioxamine (IV/IM). Oral chelators like Deferiprone and Deferasirox are used for chronic iron overload (e.g., Thalassemia), not acute poisoning. * Contraindication: Activated charcoal does NOT bind to iron (or alcohols, hydrocarbons, or corrosives). * Clinical Stages: Iron toxicity occurs in stages, starting with GI irritation (Stage 1), followed by a "latent period" (Stage 2), and then multisystem organ failure (Stage 3). * Imaging: Iron tablets are radiopaque; an abdominal X-ray is a high-yield diagnostic step to visualize the burden of ingestion.

Question 335: What is the drug of choice for mushroom poisoning?

A. Atropine (Correct Answer)
B. Physostigmine
C. Adrenaline
D. Carbachol

Explanation: **Explanation:** The correct answer is **Atropine**. **Why Atropine is the Drug of Choice:** Mushroom poisoning, specifically from species like *Amanita muscaria* or *Inocybe* species, often results in **early-onset cholinergic toxicity**. These mushrooms contain **muscarine**, which directly stimulates muscarinic receptors, leading to a "SLUDGE" syndrome (Salivation, Lacrimation, Urination, Defecation, GI distress, and Emesis) along with bradycardia and bronchoconstriction. Atropine is a **competitive muscarinic antagonist** that crosses the blood-brain barrier. It effectively reverses these life-threatening parasympathetic effects by blocking the action of muscarine at the receptor level. **Analysis of Incorrect Options:** * **Physostigmine:** This is an acetylcholinesterase inhibitor. It increases acetylcholine levels and would worsen the cholinergic crisis in mushroom poisoning. It is actually the antidote for *Atropine* (anticholinergic) overdose. * **Adrenaline:** While it can treat bradycardia or bronchospasm, it does not address the underlying receptor-level toxidrome and is not the specific antidote. * **Carbachol:** This is a cholinergic agonist. Administering it would exacerbate the symptoms of muscarine toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Early vs. Late Poisoning:** Early symptoms (within 2 hours) are usually muscarinic (treat with Atropine). Late symptoms (6–24 hours), often due to *Amanita phalloides* (Death Cap), involve **Amatoxins** which cause fatal hepatic and renal necrosis. * **Treatment for Amatoxins:** There is no specific antidote, but **Silibinin** (from milk thistle) and N-acetylcysteine are often used. * **Atropine Dosage:** In toxicology, Atropine is titrated until "atropinization" (clearing of lung secretions and reversal of bradycardia) is achieved.

Question 336: Which of the following is NOT a side effect of fenfluramine?

A. Pulmonary hypertension
B. Valvular defects
C. Sudden deaths
D. Dizziness (Correct Answer)

Explanation: **Explanation:** Fenfluramine is a sympathomimetic amine that was primarily used as an appetite suppressant (anorectic). Its mechanism involves the release of serotonin (5-HT) and inhibition of its reuptake. **Why Dizziness is the correct answer:** While fenfluramine can cause central nervous system effects, **dizziness** is not a characteristic or hallmark side effect associated with its clinical profile or its withdrawal from the market. In fact, unlike other amphetamine derivatives, fenfluramine often causes **sedation** or drowsiness rather than stimulation or dizziness. **Analysis of Incorrect Options:** * **Pulmonary Hypertension:** Fenfluramine is notorious for causing primary pulmonary hypertension (PPH). This occurs due to increased circulating serotonin levels, which cause vasoconstriction and smooth muscle proliferation in the pulmonary vasculature. * **Valvular Defects:** The drug was famously withdrawn from the market (along with dexfenfluramine) because it caused **cardiac valvulopathy** (specifically thickening of the mitral and aortic valves). This is mediated by the activation of **5-HT2B receptors** located on cardiac valves. * **Sudden Deaths:** Due to the severity of pulmonary hypertension and cardiac valvular damage, several cases of sudden cardiac death were reported, leading to its ban by the FDA in 1997. **High-Yield Clinical Pearls for NEET-PG:** * **"Fen-Phen" Combination:** The combination of Fenfluramine and Phentermine was popular for weight loss but led to the "epidemic" of valvular heart disease. * **Current Use:** Low-dose fenfluramine has recently been repurposed and FDA-approved for the treatment of seizures associated with **Dravet syndrome** and **Lennox-Gastaut syndrome**. * **Key Receptor:** Always associate **5-HT2B receptor agonism** with drug-induced valvular heart disease (also seen with Ergotamine and Pergolide).

Question 337: All of the following are parts of the treatment of Lithium toxicity, except:

A. Treating dehydration
B. Ingestion of polystyrene
C. Hemodialysis
D. Using an antagonist (Correct Answer)

Explanation: **Explanation:** The correct answer is **D (Using an antagonist)** because there is **no specific pharmacological antagonist** available for Lithium. Lithium is a monovalent cation, and its toxicity is managed through supportive care and physical removal from the body rather than receptor blockade. **Analysis of Options:** * **Treating dehydration (A):** This is a cornerstone of management. Lithium is handled by the kidneys similarly to Sodium. Dehydration leads to compensatory proximal tubular reabsorption of Sodium and Lithium, worsening toxicity. Normal saline infusion helps restore volume and promotes Lithium excretion. * **Ingestion of polystyrene (B):** Specifically, **Sodium Polystyrene Sulfonate (Kayexalate)** or newer agents like **Patiromer** can be used. While primarily used for hyperkalemia, these cation-exchange resins can bind Lithium in the gastrointestinal tract, reducing its absorption. * **Hemodialysis (C):** This is the **treatment of choice** for severe Lithium toxicity (levels >4 mEq/L or >2.5 mEq/L with symptoms). Lithium is an ideal candidate for dialysis because it is a small molecule, has a low volume of distribution, and is not protein-bound. **NEET-PG High-Yield Pearls:** 1. **Therapeutic Index:** Lithium has a very narrow therapeutic index (0.6–1.2 mEq/L). 2. **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels by decreasing its renal clearance. 3. **Gastric Lavage:** Useful only if the patient presents very early (within 1 hour), but **Activated Charcoal is ineffective** as it does not bind to metals/ions like Lithium. 4. **Whole Bowel Irrigation:** Recommended for toxicity involving sustained-release preparations.

Question 338: A 29-year-old medical student developed a positive PPD test and was started on isoniazid (INH) and rifampin prophylaxis. Three months into her therapy, she began to experience muscle fasciculations and convulsions. Administration of which of the following vitamins might have prevented these symptoms?

A. Niacin
B. Pyridoxine (Correct Answer)
C. Riboflavin
D. Thiamine

Explanation: **Explanation:** The clinical presentation of muscle fasciculations and convulsions in a patient taking **Isoniazid (INH)** is a classic manifestation of **Vitamin B6 (Pyridoxine) deficiency**. **Why Pyridoxine is the correct answer:** Isoniazid is structurally similar to pyridoxine. It causes deficiency through two primary mechanisms: 1. It inhibits the enzyme **pyridoxine phosphokinase**, which converts pyridoxine to its active form, pyridoxal-5-phosphate (PLP). 2. It reacts with PLP to form a hydrazone complex that is rapidly excreted in the urine. PLP is a vital cofactor for the enzyme **glutamic acid decarboxylase**, which converts glutamate (an excitatory neurotransmitter) into **GABA** (the primary inhibitory neurotransmitter). A lack of GABA leads to CNS over-excitation, resulting in muscle twitching, peripheral neuropathy, and seizures. **Why the other options are incorrect:** * **Niacin (B3):** While INH can theoretically cause Pellagra-like symptoms (as B6 is needed to convert tryptophan to Niacin), the acute neurological symptoms like convulsions are specifically due to GABA depletion from B6 deficiency. * **Riboflavin (B2) & Thiamine (B1):** Deficiency of these vitamins does not typically present with acute convulsions in the context of INH therapy. Thiamine deficiency is associated with Beriberi or Wernicke-Korsakoff syndrome. **NEET-PG High-Yield Pearls:** * **Prophylaxis:** To prevent neurotoxicity, 10–50 mg/day of Pyridoxine is co-administered with INH, especially in high-risk groups (alcoholics, diabetics, pregnant women, and "slow acetylators"). * **Treatment:** For INH-induced seizures, high doses of IV Pyridoxine are required to restore GABA levels. * **Metabolism:** INH is metabolized by **Acetylation** (Phase II reaction). Slow acetylators are at a higher risk of peripheral neuropathy.

Question 339: All of the following drugs are nephrotoxic, EXCEPT:

A. Lithium
B. Gentamicin
C. Chlorpromazine (Correct Answer)
D. Cephalosporins

Explanation: The correct answer is **Chlorpromazine**. Chlorpromazine is a typical antipsychotic (phenothiazine) primarily metabolized by the liver. It is not associated with direct nephrotoxicity; instead, its significant side effects include extrapyramidal symptoms, cholestatic jaundice, and photosensitivity. **Analysis of Options:** * **Lithium (Option A):** Lithium is a classic nephrotoxic drug. It is excreted unchanged by the kidneys and can cause **Nephrogenic Diabetes Insipidus (NDI)** by interfering with ADH action in the collecting ducts. Long-term use can also lead to chronic interstitial nephritis. * **Gentamicin (Option B):** Aminoglycosides like Gentamicin are notorious for causing **Acute Tubular Necrosis (ATN)** [2]. They accumulate in the proximal convoluted tubule (PCT) cells, leading to dose-dependent, reversible renal failure [2]. * **Cephalosporins (Option D):** Certain cephalosporins (especially first-generation like Cephaloridine) are nephrotoxic. When used in high doses or combined with loop diuretics/aminoglycosides, they can cause tubular necrosis or interstitial nephritis. **NEET-PG High-Yield Pearls:** 1. **Drug-Induced NDI:** Lithium is the most common cause. Treatment involves stopping the drug and starting **Amiloride** (which blocks lithium entry into the ENaC channels). 2. **Aminoglycoside Toxicity:** Gentamicin causes ATN (nephrotoxicity) and ototoxicity [1], [2]. Nephrotoxicity is usually reversible, but ototoxicity is often permanent [2]. 3. **Amphotericin B:** Another high-yield nephrotoxic drug that causes "Type 1 Renal Tubular Acidosis" and significant potassium/magnesium wasting. 4. **Contrast-Induced Nephropathy:** Prevented primarily by adequate **pre-procedure hydration** with normal saline.

Question 340: Which of the following is not an ototoxic drug?

A. Paracetamol (Correct Answer)
B. Cisplatin
C. Quinine
D. Erythromycin

Explanation: **Explanation:** Ototoxicity refers to drug-induced damage to the inner ear, affecting hearing (cochlear damage) or balance (vestibular damage). **1. Why Paracetamol is the correct answer:** Paracetamol (Acetaminophen) is a centrally acting analgesic and antipyretic. It does not possess ototoxic properties. While its metabolite (NAPQI) is highly hepatotoxic in overdose, it does not interfere with the hair cells of the cochlea or the stria vascularis. **2. Why the other options are wrong:** * **Cisplatin:** A potent platinum-based chemotherapeutic agent. It is notoriously ototoxic, causing permanent, bilateral, high-frequency hearing loss by generating reactive oxygen species (ROS) that destroy hair cells in the Organ of Corti. * **Quinine:** Used for malaria, it causes a constellation of symptoms known as **Cinchonism**, which includes tinnitus, hearing loss, and vertigo. This is usually reversible upon discontinuation. * **Erythromycin:** A macrolide antibiotic that can cause sensorineural hearing loss, especially when administered in high doses intravenously or in patients with renal impairment. **High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycosides:** Most common cause of drug-induced ototoxicity. **Amikacin/Neomycin** are more cochleotoxic; **Streptomycin/Gentamicin** are more vestibulotoxic. * **Loop Diuretics:** (e.g., Furosemide, Ethacrynic acid) cause ototoxicity by affecting the ion transport in the stria vascularis. * **Salicylates (Aspirin):** High doses cause reversible tinnitus (often the first sign of toxicity). * **Vancomycin:** Can potentiate the ototoxicity of aminoglycosides when used in combination.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free